We are working with a mid-sized biotech who are currently leading their field in the design of novel therapies in the treatment of cancer. This commercial-stage company has five ongoing clinical stage programs in their oncology pipeline, as well as advanced pre-clinical programs in other therapeutic areas. Due to the company's recent success and secured funding, they are looking to expand their Translational Medicine team in the UK. Joining this company at the most exciting time in their history, means you will be part of a collegial team that values innovative ways of thinking. Being an employee centric business, they cherish entrepreneurship and diversity. The successful candidate will have the following: Deep understanding of cancer biology and tumour models Substantial experience analysing mechanisms of drug resistance in cancers Background in cellular techniques and immunoassays (Elispots, ELISA, multiplex assays, killing assays) Excellent communication and time management skills Ability to work independently and as part of a team For more information, please contact .